Provided by Tiger Trade Technology Pte. Ltd.

Cabaletta Bio

2.68
-0.1400-4.96%
Post-market: 2.700.0200+0.75%19:35 EDT
Volume:2.80M
Turnover:7.75M
Market Cap:297.48M
PE:-1.28
High:2.95
Open:2.79
Low:2.63
Close:2.82
52wk High:3.78
52wk Low:0.9857
Shares:111.00M
Float Shares:86.04M
Volume Ratio:1.41
T/O Rate:3.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1000
EPS(LYR):-2.1000
ROE:-126.98%
ROA:-61.49%
PB:2.65
PE(LYR):-1.28

Loading ...

Cabaletta Bio Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Mar 24

Cabaletta Bio Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 24

Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock

TIPRANKS
·
Mar 24

Cabaletta Bio price target lowered to $13 from $14 at Morgan Stanley

TIPRANKS
·
Mar 24

Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Cabaletta Bio (CABA)

TIPRANKS
·
Mar 24

Cabaletta Bio price target raised to $16 from $15 at Guggenheim

TIPRANKS
·
Mar 24

Cabaletta Bio Updates Rese-cel Programs and Financial Outlook

TIPRANKS
·
Mar 23

Cabaletta Bio Q4 EPS $(0.40) Beats $(0.47) Estimate

Benzinga
·
Mar 23

Cabaletta Bio Publishes Corporate Presentation on Rese-cel CD19-CAR T Development for Autoimmune Diseases

Reuters
·
Mar 23

Cabaletta Bio expects initial RESET-SLE no-preconditioning rese-cel data in 1H26

Reuters
·
Mar 23

Cabaletta Bio Q4 net loss rises 29% to USD 42 million as R&D spending jumps 42% to USD 36 million

Reuters
·
Mar 23

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 23

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 09

Cabaletta Bio Publishes Corporate Presentation on Rese-cel CD19-CAR T Therapy for Autoimmune Diseases

Reuters
·
Mar 02

Cabaletta Bio to Join Fireside Chat at TD Cowen 46th Annual Health Care Conference

Reuters
·
Feb 24

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Ocular Therapeutix (OCUL)

TIPRANKS
·
Feb 05

Cabaletta Bio to Participate in Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Feb 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Feb 03

Cabaletta Bio, Inc. (NASDAQ:CABA) institutional owners may be pleased with recent gains after 9.7% loss over the past year

Simply Wall St.
·
Jan 22